Back to the search results

HELIOS Klinikum Erfurt

HELIOS Klinikum Erfurt
HELIOS Klinikum Erfurt

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361-7810
Fax: 0361-781-1002
Mail: ed.nekinilk-soileh@trufre.ofni

https://www.helios-gesundheit.de/kliniken/erfurt/
  • Number of beds: 1.261
  • Number of specialist departments: 31
  • Number of inpatient cases: 45.851
  • Number of partial inpatient cases: 779
  • Number of outpatient cases: 87.723
  • Number of cases of inpatient-equivalent psychiatric treatment (StäB): 168
  • Hospital owners: Helios Klinikum Erfurt GmbH
  • Type of provider: privat
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Quantity performed 29
Exception? No exception
Quantity performed 20
Exception? No exception
Quantity performed 45
Exception? No exception
Quantity performed 88
Exception? No exception
Quantity performed 25
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 29
Quantity forecast year: 26
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 20
Quantity forecast year: 16
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 45
Quantity forecast year: 43
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 88
Quantity forecast year: 88
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 25
Quantity forecast year: 23
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ02 Quality assurance measures for the inpatient care of children and adolescents with haemato-oncological diseases
CQ03 Quality assurance measures for the implementation of positron emission tomography (PET) in hospitals for the indications non-small-cell lung cancer (NSCLC) and solid pulmonary nodules
CQ05 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ25 Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
CQ04 Measures for quality assurance in the implementation of proton therapy in hospitals for the indication rectal carcinoma
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes
Number Group
295 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
212 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
187 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

Konzept Risikomanagement Helios Klinikum Erfurt

01.08.2023

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Versorgung der Patientinnen und Patienten mit patientenindividuell abgepackten Arzneimitteln durch die Krankenhausapotheke (z.B. Unit-Dose-System)
  • Sonstige_elektronische_Unterstuetzung
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Andere_Massnahme
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Lehre und Lehrauftrag an den Universitäten Jena, Frankfurt, Freiburg, Regensburg, Greifswald, Technische Universität Ilmenau

Explanation

Mentorenprojekt der LÄK Thüringen, EANS-Observership-Programm (mit internationalen Fachärzten und AiW)

Explanation

u.a.Uni Jena, Uni Leipzig, IMTEK Freiburg, Neurochirurgie Uni Freiburg, HNO Uni Saarbrücken, Psychologie Uni Giessen, Neurofibromatoseambulanz Uni Hamburg

Explanation

u.a. ADRISK: Multicenter randomized Phase II study within the German interdisciplinary study group of German Cancer Society (IAG KHT) IMSTAR HN: Multicenter randomized controlled phase III study.

Explanation

Uni Jena, Uni Leipzig

Explanation

Explanation

u.a. Lehrbuch Biomedizinische Technik, Band XI: Neurotechnik

Explanation

Universitätsmedizin Jena, Greifswald

Training in other healing professions
Comment

Michael Lorenz

Patientenfürsprecher

Nordhäuser Straße 74
99089 Erfurt

Phone: 0152 -5472618-
Mail: ed.tiehdnuseg-soileh@znerol.leahcim

Christine Tischer

Mitarbeiterin Ärztlicher Direktor

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-2001
Mail: ed.tiehdnuseg-soileh@rehcsit.enitsirhc

Scheibe Manuela

Qualitätsmanagement

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-4810
Mail: ed.tiehdnuseg-soileh@ebiehcS.aleunaM

Scheibe Manuela

Qualitätsmanagement

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-4810
Mail: ed.tiehdnuseg-soileh@ebiehcS.aleunaM

Prof. Dr. med. Heinrich Volker Groesdonk

Vorsitzender

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-2001
Mail: ed.tiehdnuseg-soileh@knodseorG.hcirnieH

Prof. Dr. med. Heinrich Volker Groesdonk

Vorsitzender

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-2001
Mail: ed.tiehdnuseg-soileh@knodseorG.hcirnieH

Drug commission

Diana Schenk

Integrationsbeauftragte

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-3010
Mail: ed.tiehdnuseg-soileh@knehcS.anaiD

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361-7810
Fax: 0361-781-1002
Mail: ed.nekinilk-soileh@trufre.ofni

Jan Wagner

stellv. Pflegedirektion

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-3006
Mail: ed.tiehdnuseg-soileh@rengaw.naj

Martin Guth

stellv. Pflegedirektion

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-5351
Mail: ed.tiehdnuseg-soileh@htug.nitram

Jan Wagner

stellv. Pflegedirektion

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-3006
Mail: ed.tiehdnuseg-soileh@rengaw.naj

Martin Guth

stellv. Pflegedirektion

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-5351
Mail: ed.tiehdnuseg-soileh@htug.nitram

Florian Lendholt

Klinikgeschäftsführer

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-1001
Mail: ed.tiehdnuseg-soileh@tlohdneL.nairolF

Florian Lendholt

Klinikgeschäftsführer

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-1001
Mail: ed.tiehdnuseg-soileh@tlohdneL.nairolF

Prof. Dr. med. Heinrich Volker Groesdonk

Ärztlicher Direktor

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-2001
Mail: ed.tiehdnuseg-soileh@knodseorG.hcirnieH

Prof. Dr. med. Heinrich Volker Groesdonk

Ärztlicher Direktor

Nordhäuser Straße 74
99089 Erfurt

Phone: 0361 -781-2001
Mail: ed.tiehdnuseg-soileh@knodseorG.hcirnieH

No

IK: 261601021

More IK: 261601021

Location number: 771835000

Old location number: 771835000

Hospital portrait for download